Defining insulin-like growth factor-I deficiency

Hormone Research

Volumn 65, Issue SUPPL. 1, 2006, Pages 9-14

  Ranke, Michael B ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C;

CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; GROWTH DISORDER; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE RELEASE; HORMONE SENSITIVITY; HUMAN; INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY; LARON SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW;

ANIMALS; ENDOCRINE SYSTEM; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I;

EID: 33644621838     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090641     Document Type: Review

References (37)

1. Ranke MB: Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol Metab 2005;16:190-197.
2. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB: Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:1610-1616.
3. Laron Z: Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab 2004;89:1031-1044.
4. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369-390.
5. Jorge AA, Souza SC, Arnhold IJ, Mendonca BB: Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene. J Clin Endocrinol Metab 2002;87:469-472.
6. Kofoed EM, Hwa V, Little B, et al: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003;349:1139-1147.
7. Milward A, Metherell L, Maamra M, et al: Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction. J Clin Endocrinol Metab 2004;89:1259-1266.
8. Tiulpakov A, Rubtsov P, Dedov I, et al: A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. J Clin Endocrinol Metab 2005;90:542-547.
9. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-1367.
10. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-163.
11. Abuzzahab MJ, Schneider A, Goddard A, et al: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003;349:2211-2222.
12. Savage MO, Blum WF, Ranke MB, et al: Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 1993;77:1465-1471.
13. Woods KA, Dastot F, Preece MA, et al: Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997;82:3529-3535.
14. Ranke MB: Diagnosis of growth hormone deficiency and growth hormone stimulation tests; in Ranke MB (ed): Diagnostics of Endocrine Function in Children and Adolescents. Basel; Karger, 2003, pp 107-128.
15. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al: Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-1540.
16. Schwarze CP, Wollmann HA, Binder G, Ranke MB: Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatr Suppl 1999;88:200-208.
17. Ranke MB, Feldt-Rasmussen U, Bang P, et al: How should insulin-like growth factor I be measured? A consensus statement. Horm Res 2001;55(suppl 2):106-109.
18. Juul A, Flyvbjerg A, Frystyk J, Muller J, Skakkebaek NE: Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf) 1996;44:515-523.
19. Ranke MB, Schweizer R, Lindberg A, et al: Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experience. Horm Res 2004;62(suppl 1):17-25.
20. Attie KM, Carlsson LM, Rundle AC, Sherman BM: Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. J Pediatr 1995;127:244-250.
21. Goddard AD, Covello R, Luoh SM, et al: Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 1995;333:1093-1098.
22. Salerno M, Balestrieri B, Matrecano E, et al: Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 2001;86:3882-3888.
23. Rosenfeld RG: The IGF system: new developments relevant to pediatric practice. Endocr Dev 2005;9:1-10.
24. Rudman D, Kutner MH, Blackston RD, Cushman RA, Bain RP, Patterson JH: Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med 1981;305:123-131.
25. Cutfield WS, Hofman PL, Vickers M, Breier B, Blum WF, Robinson EM: IGFs and binding proteins in short children with intrauterine growth retardation. J Clin Endocrinol Metab 2002;87:235-239.
26. Dunger DB, Regan FM, Acerini CL: Childhood and adolescent diabetes. Endocr Dev 2005;9:107-120.
27. Backeljauw PF, Underwood LE: Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - a clinical research center study. GHIS Collaborative Group. J Clin Endocrinol Metab 1996;81:3312-3317.
28. Guevara-Aguirre J, Vasconez O, Martinez V, et al: A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab 1995;80:1393-1398.
29. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Wilton P: Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes. Horm Res 1999;51:128-134.
30. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P: Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia Study Group on Insulin-Like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paediatr Suppl 1994;399:117-124.
31. Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG: The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab 2001;86:5176-5183.
32. Blair JC, Camacho-Hubner C, Miraki MF, et al: Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature. Clin Endocrinol (Oxf) 2004;60:163-168.
33. Cotterill AM, Camacho-Hubner C, Duquesnoy P, Savage MO: Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature. Clin Endocrinol (Oxf) 1998;48:719-724.
34. Selva KA, Buckway CK, Sexton G, et al: Reproducibility in patterns of IGF generation with special reference to idiopathic short stature. Horm Res 2003;60:237-246.
35. Schuett BS, Weber K, Elmlinger MW, Ranke MB: Measuring IGF-I, IGFBP-2 and IGFBP-3 from dried blood spots on filter paper is not only practical but also reliable. Growth Horm IGF Res 2003;13:75-80.
36. Rosenfeld RG: Broadening the growth hormone insensitivity syndrome. N Engl J Med 1995;333:1145-1146.
37. Dos SC, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P: A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 2004;36:720-724.